•
Kind Pharmaceuticals LLC, a Sino-US pharmaceutical company, along with its Chinese affiliate Hangzhou Andao Pharmaceutical Ltd, has announced an amicable resolution to a trade secrets dispute with Fibrogen Inc. (NASDAQ: FGEN). The dispute originated from a lawsuit initiated by Fibrogen in November 2022 against Andao, Kind Pharma, and individual defendants…